DANIEL PLUMERI: Open Payments
NPI 1447767983 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,031 in 34 payments from 14 companies in 2025. Trend: 2023 $928 · 2024 $5,789 · 2025 $3,031
Speaker / faculty: $1,776Food & beverage: $1,174Education: $43Travel & lodging: $39
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 6 | $2,104 |
| Medtronic, Inc. | 4 | $289 |
| BETA BIONICS, INC. | 8 | $239 |
| Mannkind Corporation | 3 | $95 |
| Sequel Med Tech, LLC | 2 | $48 |
| ABBVIE INC. | 2 | $39 |
| IBSA Pharma Inc. | 2 | $34 |
| Soleno Therapeutics, Inc. | 1 | $32 |
| Neurocrine BioSciences, Inc. | 1 | $31 |
| Lilly USA, LLC | 1 | $28 |
Products named: DEXCOM G7 GSS (161), MINIMED 780G, iLet Bionic Pancreas, AFREZZA, TWIIST, Tirosint, VYKAT XR, CRENESSITY.
Industry payments across NY — which companies pay providers there.
